AzTrials
AzTrials

Anorexia NervosaNCT04095741

Characteristics of Autism Spectrum Disorder in Minors With Anorexia Nervosa in Remission

An observational study of Anorexia Nervosa and Autism Spectrum Disorder, run by Universitair Ziekenhuis Brussel at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

With this investigation, researchers wil look for a link between the appearance of anorexia nervosa and autism spectrum disorders in minors. Previous studies made clear already that patients with anorexia nervosa show elevated characteristics of autism spectrum disorder, when being meassured in adults and in patients… Read more about this study

Who is it for?
Ages Up to 18 years
Conditions the study is for
Anorexia Nervosa, Autism Spectrum Disorder
What is being tested?
Questionnaires
How many people
34 participants
Where
1 siteBelgium
Study dates
1 Oct 2019to 31 Mar 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 18 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: Patients were previously treated in UZ Brussel for anorexia nervosa. Intake happened at least one year ago.

Who may be able to join

  • Patients speaking Dutch
  • Previously treated in UZ Brussel for anorexia nervosa
  • Informed consent signed by children and parent(s)

Who cannot join

  • Patients and/or parents don't speak Dutch
  • Adults
  • No informed consent obtained

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • UZ Brussel

    Brussels

    Sara Wouters, Dr.

    Joni Roelandt, Dr.

Other trials in Belgium

About this study

With this investigation, researchers wil look for a link between the appearance of anorexia nervosa and autism spectrum disorders in minors. Previous studies made clear already that patients with anorexia nervosa show elevated characteristics of autism spectrum disorder, when being meassured in adults and in patients in the acute fase of their anorexia nervosa. The purpose of this invenstigation is to see if their is also an elevated incidence of characteristics of autism spectrum disorder in minors with anorexia nervosa in remission.

Read the detailed description

34 patients who are still minors and were previously treated in the Child and Adolescent Psychiatry Department (PAika) of the University Hospital in Brussels, will be contacted to ask if they would volunteer in this investigation. If the minors and their parents give their permission, they will be asked to fill in multiple questionnaires, measuring the current symptoms of anorexia nervosa, characteristics of autism spectrum disorder and global functioning of the minors. The questionnaires will be send and returned by post.

Being tested
Questionnaires
Medical subject headings
Anorexia Nervosa, Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnairesDiagnostic test

    Filling in questionnaires of general functioning and symptomes of anorexia nervosa and autism spectrum disorders will demanded to children and their parents. The children all have a history of anorexia nervosa.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Symptoms of autism spectrum disorder

    Symptoms of autism spectrum disorder will be measured by questionnaires, filled in by the minors (by the Autism-spectrum Quotient) and their parents (by the Social Responsiveness Scale-2 and the Social Communication Questionnaire).

    Measured: The measurment will be done once during the period of October 2019 to March 2020.

Secondary outcomes (2)
  1. Global functioning

    Global functioning will be measured by questionnaires, filled in by the minors (by the Youth Self Report) and their parents (by the Child Behavior Checklist).

    Measured: The measurment will be done once during the period of October 2019 to March 2020

  2. Symptoms of anorexia nervosa

    Symptoms of anorexia nervosa will be measured by questionnaires, filled in by the minors (by the Eating Disorder Examination Questionnaire and the Child Eating Disorder Examination Questionnaire) and their parents (by the Anorectic Behavior Observation Scale).

    Measured: The measurment will be done once during the period of October 2019 to March 2020

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2019
  2. Study start1 Oct 2019 (estimated)
  3. Primary completion31 Mar 2020 (estimated)
  4. Study completion31 Mar 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
34 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04095741
Sponsor's protocol ID
PAIKA2019STUDIE01
Status last verified
Sep 2019
First submitted
17 Apr 2019
Last updated
19 Sep 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Anorexia Nervosa and Autism Spectrum Disorder, run by Universitair Ziekenhuis Brussel at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Sep 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Symptoms of autism spectrum disorder (time frame: The measurment will be done once during the period of October 2019 to March 2020.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in